Why Shares of Zafgen Skyrocketed Today -- The Motley Fool
( What: Shares of Zafgen NASDAQ:ZFGN), a small-cap anti-obesity drugmaker, gained as much as 94% today on exceptionally high volume after the company announced that its twice-weekly injected drug, beloranib, met both of its co-primary endpoints in a pivotal late-stage study.
Wednesday, January 20, 2016
$ZFGN have to clear up the drug's clinical status before applying for regulatory approval #Realtime @ $8.80 UP 56%
Subscribe to:
Post Comments (Atom)
Powered By
Find Out MORE
No comments:
Post a Comment